Skip to main content
. 2022 May 24;11:32. doi: 10.1186/s40164-022-00284-z

Fig. 2.

Fig. 2

The proportions of patients with various mutations based on age (a), splenomegaly (b), cytogenetic risk (c), HB (d), PLT (e), and WBC (f). The correlation of total CMML mutations versus age at diagnosis (g), WBC (h), Hb (i), and PLT level (j)